publication venue for
- Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity.. 57. 2020
- Integrating genomics into prognostic models for AML.. 51. 2014
- Introduction. What's happening with heparin-induced thrombocytopenia: emerging preventive, diagnostic, and management strategies.. 42. 2005
- Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura.. 37. 2000
- The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis.. 37. 2000
- Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.. 34. 1997
- Interferon alfa: effects of long-term treatment for polycythemia vera.. 34. 1997
- T-cell depletion and allogeneic bone marrow transplantation.. 29. 1992
- The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.. 25. 1988
- Advances in chemotherapy for large cell lymphoma.. 24. 1987
- The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma.. 24. 1987
- The bone marrow in polycythemia vera.. 12. 1975
- Acquired lipidosis: Gaucher-like cells and "blue cells" in chronic granulocytic leukemia.. 9. 1972
- The regulation of porphyrin and heme synthesis.. 5. 1968
- The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. 2009
- Delayed diagnosis of congenital sideroblastic anemia.. 55. 2017
- New thrombopoietic agents: introduction.. 47. 2010
- Implications of signal transduction inhibition for the treatment of chronic myeloid leukemia.. 38. 2001
- Measurable residual disease after CAR T-cell therapy. 2023
- Genetic and epigenetic determinants of AML pathogenesis. 2018
- Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods. 2018
- Haploidentical cord transplantation-The best of both worlds. 2016
- The epigenetic basis of diffuse large B-cell lymphoma. 2015
- Current status of the role of PET imaging in diffuse large B-cell lymphoma. 2015
- Thrombopoietin receptor agonists: a critical review. 2014
- Advances in the development of animal models of myeloid leukemias. 2013
- Is there a role for "watch and wait" in patients with mantle cell lymphoma? 2011
- Myelomagenesis: capturing early microenvironment changes. 2011
- Thrombopoietic agents in immune thrombocytopenia. 2010
- Therapeutic approaches to secondary immune thrombocytopenic purpura. 2009
- Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia. 2008
- Targeted treatment and new agents in diffuse large B-cell lymphoma. 2008
- Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma. 2008
- New drugs for the treatment of advanced-stage diffuse large cell lymphomas. 2006
- Review of therapies for immune thrombocytopenic purpura. 2006
- Treatment of immune thrombocytopenic purpura in adults. 2006
- Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome. 2006
- Evolving management strategies for heparin-induced thrombocytopenia. 2005
- Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. 2005
- Imatinib treatment: specific issues related to safety, fertility, and pregnancy. 2003
- Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia. 2003
- Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes. 2002
- Chelation therapy in beta-thalassemia: an optimistic update. 2001
- Toward gene therapy for disorders of globin synthesis. 2001
- Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. 2001
- Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. 2001
- Fc receptor blockade and immune thrombocytopenic purpura. 2000
- Idiopathic immune thrombocytopenic purpura: an update. 2000
- The spleen: anatomy and anatomical function. 2000
- Thrombophilias: diagnosis and treatment of thrombophilia relating to contraception and pregnancy. 1999
- The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia. 1998
- Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. 1998
- Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. 1998
- Recent advances in the treatment of idiopathic thrombocytopenic purpura: the anti-D clinical experience. 1998
- Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome. 1997
- Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine. 1995
- The natural history of chronic myelogenous leukemia in the interferon era. 1995
- "Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment. 1991
- Intensive therapy for adult acute lymphoblastic leukemia. 1991
- New pharmacologic approaches to treatment of leukemia. 1991
- Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy. 1991
- Interferon in the treatment of myeloproliferative diseases. 1990
- Monoclonal antibodies in the treatment of hematopoietic malignancies. 1988
- Survival of intracellular pathogens within human mononuclear phagocytes. 1988
- Biology of chronic myelogenous leukemia: is discordant maturation the primary defect? 1988
- Marrow transplantation for congenital disorders. 1984
- The treatment of chronic lymphocytic leukemia. 1969